ACLARION INC

ACON stock represents ownership shares in Aclarion, Inc., a company focused on improving surgical and healthcare outcomes. Aclarion uses proprietary augmented intelligence and biomarker technology. Shares trade on the Nasdaq under the ticker ACON. The stock gives investors exposure to a small-cap healthcare technology company. Users should review the company's latest filings and profile for current details.

The current price of ACON stock changes throughout each trading day based on supply and demand. The latest quote, intraday moves, and closing price are shown on the ACON stock page. Because ACON is a small-cap stock, its price can be more sensitive to news and trading volume. Check the page's live data for the most up-to-date price.

ACON is a small-cap healthcare technology stock, and small-cap shares often show higher price volatility than large-cap stocks. Volatility can increase around earnings reports, financing updates, clinical or regulatory news, and changes in market sentiment. The page typically displays metrics such as daily price swings and the 52-week range, which can help investors assess how widely ACON has traded.

Valuation for ACON depends on its stage as a small-cap company. If ACON has little or no earnings, price-to-earnings may be less useful, and investors may instead examine price-to-sales, price-to-book, cash position, revenue growth, and cash burn. Comparing these metrics with peers in healthcare technology can provide context. The page's valuation section should show the latest available ACON figures.

Start with ACON's income statement, balance sheet, and cash flow statement filed with the SEC. Revenue growth, gross margin, operating expenses, net loss or income, and cash used in operations are key for a small-cap healthcare technology company. Also review cash and equivalents, debt, and share count changes. The page's financials section provides the latest reported figures for ACON.

ACON carries risks common to small-cap healthcare technology companies, including limited revenue, dependence on product adoption, regulatory and reimbursement uncertainty, competition, and potential need for additional financing. Its share price may also be volatile and sensitive to news. Investors should review ACON's risk factors in its latest annual report or quarterly filings for company-specific details.